Cell Point (India) (NSE:CELLPOINT) Beta: 0.7882 (As of Jun. 26, 2026)


NSE:CELLPOINT Cell Point (India) Ltd NSE:CELLPOINT
73 GF Score
Price ₹15.00
GF Value ₹34.72
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Cell Point (India) Beta?

Cell Point (India) NSE:CELLPOINT -5.36% 73 Beta is 0.7882 as of Jun. 26, 2026. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 73/100 and a GF Value™ of ₹34.72 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Cell Point (India)'s Beta is 0.7882.


Cell Point (India)  (NSE:CELLPOINT) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Cell Point (India) Beta Related Terms


Cell Point (India) Beta Historical Data

* Premium members only.

The historical data trend for Cell Point (India)'s Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) Beta Chart

Cell Point (India) Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Cell Point (India) Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:CELLPOINT vs CASY, WSM, ULTA: Beta Comparison

For the Specialty Retail subindustry, Cell Point (India)'s Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Point (India) Beta vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s Beta distribution charts can be found below:

* The bar in red indicates where Cell Point (India)'s Beta falls into.


NSE:CELLPOINT
73GF Score
Cell Point (India) Ltd NSE:CELLPOINT
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Point (India) Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.7882 mean?
Cell Point (India) (NSE:CELLPOINT) has a Beta of 0.7882 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cell Point (India) and its competitors.
Is Cell Point (India)'s Beta too high?
Cell Point (India)'s current Beta is 0.7882. Overall, Cell Point (India) has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s Beta compare to CASY and WSM?
Cell Point (India)'s Beta of 0.7882 can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Retail - Cyclical company?
A good Beta depends on the Retail - Cyclical industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cell Point (India) and its competitors. Cell Point (India)'s current Beta is 0.7882. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.72, compared to a current price of ₹15.00 — trading 56.8% below its estimated fair value. The current Beta is 0.7882. Cell Point (India)'s overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current Beta is 0.7882 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued. The current stock price of ₹15.00 is trading 56.8% below its estimated GF Value™ of ₹34.72. GuruFocus considers Cell Point (India) to be Significantly Undervalued.

Key valuation signals for NSE:CELLPOINT:

  • Beta: 0.7882
  • GF Value™: ₹34.72 vs. price of ₹15.00 (56.8% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cell Point (India) Business Description

Address Lalitha Colony, Door No. 30-15-134, Dabagardens, Visakhapatnam, AP, IND, 530020
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
73GF Score

Get the complete analysis for NSE:CELLPOINT

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.00
Price
₹34.72
GF Value